Does anyone lives in the Houston area? I found this article regarding a study to be done on keratosis pilaris. (See last paragraph.)
Dermatology clinic seeks volunteers
The University of Texas Medical School at Houston's Department of Dermatology is recruiting study volunteers for several clinical trials.
One study concerns the effectiveness of a Food and Drug Administration-approved treatment for "keloids," which are scars that continue to grow after they should have stopped. When the skin is injured, cells grow back to fill in the gap in the skin, usually stopping when the scar tissue is even with the contour of the skin.
When the cells keep reproducing, the result is called a hypertrophic (overgrown) scar, or keloid.
The development of keloids is genetic, and seems to most frequently affect people of African or Asian descent.
Adult participants must visit the dermatology clinic four times during four months for treatment.
They must have at least one keloid on their upper chest, back or an arm for at least seven months.
The treatment is safe, painless and non-invasive, and compensation is available.
Researchers also are studying a painless FDA-approved topical treatment for poison ivy. Adult volunteers must have had a poison ivy outbreak in the past, and be able to visit the dermatology clinic six times during the course of the study. Compensation is available.
Another study deals with "keratosis pilaris." About 40 percent of all adolescents and adults experience keratosis pilaris, which appears as small colorless or white bumps on the arms, thighs and buttocks. The dermatology clinic is studying the effectiveness of a safe, painless topical treatment specifically formulated to treat keratosis pilaris. Compensation is available, and the study will accept volunteers aged 12 and older.
For more information about participating in these studies, call 713-500-8266.
Dermatology clinic seeks volunteers
The University of Texas Medical School at Houston's Department of Dermatology is recruiting study volunteers for several clinical trials.
One study concerns the effectiveness of a Food and Drug Administration-approved treatment for "keloids," which are scars that continue to grow after they should have stopped. When the skin is injured, cells grow back to fill in the gap in the skin, usually stopping when the scar tissue is even with the contour of the skin.
When the cells keep reproducing, the result is called a hypertrophic (overgrown) scar, or keloid.
The development of keloids is genetic, and seems to most frequently affect people of African or Asian descent.
Adult participants must visit the dermatology clinic four times during four months for treatment.
They must have at least one keloid on their upper chest, back or an arm for at least seven months.
The treatment is safe, painless and non-invasive, and compensation is available.
Researchers also are studying a painless FDA-approved topical treatment for poison ivy. Adult volunteers must have had a poison ivy outbreak in the past, and be able to visit the dermatology clinic six times during the course of the study. Compensation is available.
Another study deals with "keratosis pilaris." About 40 percent of all adolescents and adults experience keratosis pilaris, which appears as small colorless or white bumps on the arms, thighs and buttocks. The dermatology clinic is studying the effectiveness of a safe, painless topical treatment specifically formulated to treat keratosis pilaris. Compensation is available, and the study will accept volunteers aged 12 and older.
For more information about participating in these studies, call 713-500-8266.
